SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ACCELERON PHARMA INC, ACCELERON PHARMA, INC, Acceleron Pharma Inc.
Client-Reported Lobbying Expenses
$60K
8 filings
Firm Income Reported for This Client
$90K
Not substituted for client expenses
Summary
ACCELERON PHARMA INC is an organization, based in MA. Its political footprint includes $60K in client-reported lobbying expenses, $90K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code. Political activity spans from 2021 to 2022.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 100% YoY
2022: — (complete years)
Activity data: Senate LDA